Cognitive decline · older people with age‐related memory loss
1 finding from 1 review
Activities of daily living · older people with age‐related memory loss
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · older people with age‐related memory loss
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Specific adverse events: haemorrhage · cognitively healthy people in late life
Aspirin leads to higher adverse events (haemorrhage) compared with placebo (high certainty).
1 finding from 1 review
All‐cause mortality · cognitively healthy people in late life
Aspirin leads to higher mortality compared with placebo (high certainty).
1 finding from 1 review
Cognitive decline · cognitively healthy people in late life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Activities of daily living · cognitively healthy people in late life
Aspirin showed no clear difference in activities of daily living compared with placebo (high certainty).
1 finding from 1 review
Health‐related quality of life · cognitively healthy people in late life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of Alzheimer's disease · cognitively healthy people in late life
Other NSAIDs showed no clear difference in incidence of Alzheimer's disease compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events: myocardial infarction · cognitively healthy people in late life
Other NSAIDs showed no clear difference in adverse events –myocardial infarction compared with placebo (moderate certainty).
1 finding from 1 review
Adverse effects ‐ Stroke · cognitively healthy people in late life
Other NSAIDs showed no clear difference in adverse events – stroke compared with placebo (moderate certainty).
1 finding from 1 review
Incidence of dementia · People with MCI/prodromal AD
Souvenaid showed no clear difference in incidence of dementia compared with placebo (moderate certainty).
1 finding from 1 review
Executive function (specific cognitive function) · People with mild Alzheimer's disease
1 finding from 1 review
Functional outcomes · People with mild Alzheimer's disease
1 finding from 1 review
Quality of life · People with mild Alzheimer's disease
1 finding from 1 review
Combined cognitive‐functional outcome · People with mild Alzheimer's disease
1 finding from 1 review
Any adverse events · People with mild Alzheimer's disease
Souvenaid showed no clear difference in any adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Cognitive function · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Memory (specific cognitive function) · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Executive function (specific cognitive function) · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review